Insights On Facility Design
-
Single-Use Microbial Impactor On A Filling Line
3/6/2024
Discover the advantages of a single-use microbial impactor through a demonstration of its ease of use in an isolator and an explanation of its ability to eliminate false positives.
-
How Airflow Visualization Characterizes Pharmaceutical Sterility
2/22/2024
Explore how airflow visualization studies influence contamination control and risk management in pharmaceutical environments.
-
ISO/DTR 14644 -21 Cleanrooms And Associated Controlled Environments
2/22/2024
Here, we review the Technical Report outlining how particle counters are used to classify and monitor cleanroom performance, ensuring it meets required standards under normal operating conditions.
-
EMPQ And Validation Support Services
2/21/2024
A growing pharmaceutical/biotech company hired a global consulting firm for a project that required EMPQ services for qualification activities on a newly completed aseptic processing suite.
-
SAP S4HANA Implementation: Commissioning, Qualification, And Validation
2/20/2024
Explore how CAI helped one company navigate complications when implementing SAP and how new solutions are being developed, validated, and implemented to establish this new global ERP system.
-
How To Prove A Sterility Assurance Level Of 10⁻⁶
2/13/2024
Explore the Biological Indicator/Bioburden (BI/BB) method for achieving sterilization of products along with the prerequisite studies needed to develop the sterilization process.
-
6 Reasons To Use Biological Indicators During Your Sterilization Cycle
2/13/2024
Understand the importance of biological indicators, and learn why they should be integral to any comprehensive sterilization program.
-
Consolidating The Supply Chain For mRNA
2/12/2024
Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.
-
Mabion: Your Biologics CDMO
2/8/2024
Learn about Mabion's capabilities as a CDMO, its commitment to quality and customer satisfaction, and the crucial role the company plays in the drug development and manufacturing space.
-
Multimodal R&D Management With Incyte's Jim Lee, M.D., Ph.D.
1/18/2024
Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins at the earliest opportunity to achieve research and discovery efficiencies.